City

Ankara (1)

Ciudad de mexico (1)

Wasilkow (1)

Overall Status

Recruiting (2)

Completed (1)

Phase

n/a (1)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Ankara Universitesi Teknokent (1)

Asociacion para Evitar la Ceguera en Mexico (1)

Medical University of Bialystok (1)

Collaborator

International Olympic Committee (1)

University of Bialystok (1)

Intervention

methylprednisolone succinate 500 mg (1)

neuroimaging (1)

ophthalmology examination. (1)

recombinant human erythropoietin 4,000 ui and 2,000 ui (1)

repetitive electromagnetic stimulation (1)

vep - visual evoked potential (1)

wharton jelly derived mesenchymal stem cell (1)

Study Documents

Intervention Type

device (2)

biological (1)

diagnostic test (1)

drug (1)

Funder Type

Other (3)

Study Type

Interventional (3)

toxic optic neuropathy

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Toxic Optic Neuropathy, Treatment, Methylprednisolone Trial in Ciudad de mexico (Recombinant human erythropoietin 4,000 UI and

Recruiting

Toxic Optic Neuropathy
+3 more

Recombinant human erythropoietin 4,000 UI and 2,000 UI
Methylprednisolone succinate 500 mg

Ciudad de mexico, Mexico

Jorge Cárdenas Belaunzarán

Feb 20, 2023

Ischemic Optic Neuropathy, Optic Neuritis, Compressive Optic Neuropathy Trial in Wasilkow (Neuroimaging, VEP - visual evoked

Recruiting

Ischemic Optic Neuropathy
+5 more

Neuroimaging
+2 more

Wasilkow, Poland

Lisowski

Apr 28, 2022

Methanol Poisoning, Toxic Optic Neuropathy, Stem Cell Tyrosine Kinase 1 Y842X Trial in Ankara (Wharton jelly derived mesenchymal

Completed

Methanol Poisoning
+3 more

Wharton jelly derived mesenchymal stem cell
Repetitive electromagnetic stimulation

Ankara, Türkiye, Turkey
+1 more

May 6, 2021